BB1 BLINKLAB FPO [BB1]
Healthcare · Health Information Services
· website
$0.68
52wk 0.42 – 1.10
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About BLINKLAB FPO [BB1]
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations. The company's application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$103.45M
P/E (trailing)
—
P/E (forward)
-6.75
EPS (trailing)
-0.06
Dividend yield
—
Payout ratio
0.0%
Beta
—
EV / EBITDA
-12.80
Price / Book
14.36
ROE
-50.7%
Operating margin
-319.2%
Net margin
0.0%
Total cash
$7.88M
Total debt
$388,660
Current ratio
25.16
Debt / Equity
0.02
Free cash flow
$-14.71M
Avg volume
173,126
Latest annual results
(FY ending 30 Jun 2025)
- Revenue—
- Gross profit—
- Operating income-$6.07M
- Net income-$5.71M
- Diluted EPS-0.06
- Free cash flow-$4.30M
- Net debt-$8.58M